News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
金斯瑞生物科技(01548.HK)升19% 傳奇生物(LEGN.US)宣布治療淋巴瘤藥物初步臨床數據現積極信號
金斯瑞生物科技(01548.HK)今日高開14.99%，最高見15.6元。現報14.48元，升19.28%，成交2,986.1萬股，涉資4.37億元。該公司的美國聯營公司傳奇生物(LEGN.US)宣布其在研的體內CD19/CD20雙靶點CAR-T細胞療法LB2501在復發或難治性B細胞非霍奇金淋巴瘤(R/R B-NHL)患者中的初步臨床數據已顯示出積極信號，...
Reset
Send
The window will close in 5 seconds
金斯瑞生物科技(01548.HK)升19% 傳奇生物(LEGN.US)宣布治療淋巴瘤藥物初步臨床數據現積極信號
Close
Recommend
7
Positive
8
Negative
8
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

金斯瑞生物科技(01548.HK)  -0.440 (-3.279%)    Short selling $25.72M; Ratio 23.602%   今日高開14.99%，最高見15.6元。現報14.48元，升19.28%，成交2,986.1萬股，涉資4.37億元。

該公司的美國聯營公司傳奇生物(LEGN.US)      宣布其在研的體內CD19/CD20雙靶點CAR-T細胞療法LB2501在復發或難治性B細胞非霍奇金淋巴瘤(R/R B-NHL)患者中的初步臨床數據已顯示出積極信號，數據將在2026年歐洲血液學協會(EHA)年會的最新突破性專場中進行報告。(sl/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-04 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.